Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade + R-CHOP in B-Cell Lymphoma
NCT00169468Phase 2Completed
- Sponsor
- Lymphoma Study Association
- Start
- Jan 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of bortezomib in B cell lymphoma (2 arms), sponsored by Lymphoma Study Association. Primary endpoints: Rate of Complete Remission at 1 year and Number of Serious Adverse Events at 1 year. Started Jan 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00169468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169468.